Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.
暂无分享,去创建一个
Xiaoping Zhou | Qianghu Wang | A. Rao | Yiwen Chen | Jian Hu | A. Heimberger | Jiangong Ren | F. Lan | Hongwu Zheng | B. Segal | M. Rasband | V. Ravikumar | D. Zamler | Sharon R. Stevens | Congxin Dai | T. Shingu | Chenxi He | Yunfei Wang | Liang Yuan | Feng Zhou | Chythra R. Chandregowda
[1] Matthew Grist,et al. Remarkable Stability of Myelinating Oligodendrocytes in Mice , 2017, Cell reports.
[2] J. Auwerx,et al. PPARδ Promotes Running Endurance by Preserving Glucose. , 2017, Cell metabolism.
[3] S. Amor,et al. Multiple sclerosis animal models: a clinical and histopathological perspective , 2017, Brain pathology.
[4] R. Verhaak,et al. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation , 2016, Nature Genetics.
[5] Jeffrey L. Bennett,et al. Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases , 2016, Cell reports.
[6] S. Richard,et al. Emerging functions of the Quaking RNA‐binding proteins and link to human diseases , 2016, Wiley interdisciplinary reviews. RNA.
[7] S. Richard,et al. Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance , 2016, The Journal of Neuroscience.
[8] O. Stüve,et al. Primary progressive multiple sclerosis—why we are failing , 2016, The Lancet.
[9] S. Miller,et al. Oligodendrocyte death results in immune-mediated CNS demyelination , 2015, Nature Neuroscience.
[10] Gene W. Yeo,et al. PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy , 2015, Nature Medicine.
[11] Hans Lassmann,et al. An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.
[12] Steven D. Miller,et al. ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis , 2015, The Journal of Neuroscience.
[13] F. Finkernagel,et al. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state , 2015, Nucleic acids research.
[14] A. Ishii,et al. Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS , 2014, The Journal of Neuroscience.
[15] Samuel Bernard,et al. Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain , 2014, Cell.
[16] B. Grygiel-Górniak. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.
[17] John R. Yates,et al. Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures , 2013, Cell.
[18] Piotr Kozlowski,et al. Diffusely Abnormal White Matter in Multiple Sclerosis: Further Histologic Studies Provide Evidence for a Primary Lipid Abnormality With Neurodegeneration , 2013, Journal of neuropathology and experimental neurology.
[19] G. Hager,et al. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4 , 2012, BMC Genomics.
[20] T. Kilpatrick,et al. Myelin Gene Regulatory Factor Is Required for Maintenance of Myelin and Mature Oligodendrocyte Identity in the Adult CNS , 2012, The Journal of Neuroscience.
[21] Anthony Brown,et al. FluoroMyelin™ Red is a bright, photostable and non-toxic fluorescent stain for live imaging of myelin , 2012, Journal of Neuroscience Methods.
[22] I. Weissman,et al. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice , 2012, The Journal of experimental medicine.
[23] Donald A. Wilson,et al. ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models , 2012, Science.
[24] B. Becher,et al. Primary oligodendrocyte death does not elicit anti-CNS immunity , 2012, Nature Neuroscience.
[25] K. Nave,et al. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models , 2011, Journal of Lipid Research.
[26] Jason I. Herschkowitz,et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo , 2011, Proceedings of the National Academy of Sciences.
[27] H. Blöcker,et al. Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) , 2011, PloS one.
[28] S. Guan,et al. Analysis of proteome dynamics in the mouse brain , 2010, Proceedings of the National Academy of Sciences.
[29] Alan Peters,et al. The Effects of Normal Aging on Myelinated Nerve Fibers in Monkey Central Nervous System , 2009, Front. Neuroanat..
[30] Ryoichiro Kageyama,et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain , 2008, Nature Neuroscience.
[31] S. Richard,et al. New implications for the QUAKING RNA binding protein in human disease , 2008, Journal of neuroscience research.
[32] Roland Martin,et al. Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.
[33] K. Hirata,et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers , 2007, Glia.
[34] Yue Feng,et al. Rescuing qkv Dysmyelination by a Single Isoform of the Selective RNA-Binding Protein QKI , 2006, The Journal of Neuroscience.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Bartzokis. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.
[37] S. Ando,et al. Turnover of Myelin Lipids in Aging Brain , 2004, Neurochemical Research.
[38] B. Popko,et al. Inducible site‐specific recombination in myelinating cells , 2003, Genesis.
[39] S. Richard,et al. Nuclear Retention of MBP mRNAs in the Quaking Viable Mice , 2002, Neuron.
[40] R. Evans,et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. Bartzokis,et al. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.
[42] C. Lucchinetti,et al. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. , 2001, Trends in molecular medicine.
[43] Yue Feng,et al. Destabilization and Mislocalization of Myelin Basic Protein mRNAs in quaking Dysmyelination Lacking the QKI RNA-Binding Proteins , 2000, The Journal of Neuroscience.
[44] J. Ward,et al. Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.
[45] B. Scheithauer,et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.
[46] J. Trimmer,et al. Dependence of Nodal Sodium Channel Clustering on Paranodal Axoglial Contact in the Developing CNS , 1999, The Journal of Neuroscience.
[47] P. Mcgeer,et al. Myelin degeneration in multiple system atrophy detected by unique antibodies. , 1998, The American journal of pathology.
[48] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[49] K. Jellinger,et al. Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.
[50] W. Brück,et al. Oligodendrocytes in the early course of multiple sclerosis , 1994, Annals of neurology.
[51] R. Ledeen,et al. Long‐chain acyl‐coenzyme a synthetase in rat brain myelin , 1987, Journal of neuroscience research.
[52] A. D. Smith,et al. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.
[53] O. Koul,et al. UDP-galactose-ceramide galactosyltransferase in rat brain myelin subfractions during development. , 1980, The Biochemical journal.
[54] N. Baumann,et al. LIPID COMPOSITION OF QUAKING MOUSE MYELIN: COMPARISON WITH NORMAL MOUSE MYELIN IN THE ADULT AND DURING DEVELOPMENT 1 , 1973, Journal of neurochemistry.
[55] M. Smith,et al. The turnover of myelin in the adult rat. , 1968, Biochimica et biophysica acta.
[56] N. Baumann,et al. Fatty acid and lipid composition of the brain of a myelin deficient mutant, the "quaking" mouse. , 1968, European journal of biochemistry.
[57] R. Sidman,et al. Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System , 1964, Science.